The Patent Finder

Selecta Biosciences, Inc.

Also on record
Records under this name other than the patents Selecta Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.

Back to Selecta Biosciences, Inc.

PatentTitleStatus Expires Confidence
US 11,235,057Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,508,249Methods Related to Administering Immunosuppressants and Non-Allergenic Antigens to Reduce or Prevent Anaphylaxis
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,472,167Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both Type 1 and Type IV hypersensitivity
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,194,078Methods and Compositions Related to Combined Treatment with Anti-Inflammatories and Synthetic Nanocarriers Comprising an Immunosuppressant
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,071,114Methods and Compositions for Attenuating Gene Expression Modulating Anti-Viral Transfer Vector Immune Responses
Lapsed on the fee record
Ended Sep 11, 2026 · Medium confidence
Lapsed on the fee recordEnded Sep 11, 2026Medium confidence
US 10,046,064Methods and Compositions for Attenuating Exon Skipping Anti-Viral Transfer Vector Immune Responses
Lapsed on the fee record
Ended Aug 14, 2026 · Medium confidence
Lapsed on the fee recordEnded Aug 14, 2026Medium confidence
US 9,987,354Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
Lapsed on the fee record
Ended Jun 5, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 5, 2026From the USPTO record
US 10,441,651Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
Lapsed on the fee record
Ended Oct 15, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 15, 2023From the USPTO record
US 9,066,978Dose selection of adjuvanted synthetic nanocarriers
Lapsed on the fee record
Ended Jun 30, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jun 30, 2023From the USPTO record
US 9,006,254Immunomodulatory agent-polymeric compounds
Lapsed on the fee record
Ended Apr 14, 2023 · From the USPTO record
Lapsed on the fee recordEnded Apr 14, 2023From the USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited